Asnis G M, Sachar E J, Langer G, Halpern F S, Fink M
Psychopharmacology (Berl). 1979;66(3):247-50. doi: 10.1007/BF00428314.
Tardive dyskinesia has been hypothesized to be caused by a neuroleptic-induced dopamine hypersensitivity in the nigrostriatal system. This study evaluated with dopamine antagonists the possibility that such dopamine hypersensitivity extends to the tuberoinfundibular dopamine (TIDA) system, which regulates, by inhibition, pituitary prolactin secretion. Plasma prolactin concentrations in six patients with tardive dyskinesia were assessed in four conditions: During chronic haloperidol therapy; serially after abrupt haloperidol withdrawal; while unmediated; and in response to an acute dose of 0.5 mg IM haloperidol. In all four conditions, prolactin responses did not differ from those observed in normal subjects and schizophrenic patients without tardive dyskinesia. It is concluded that there is no evidence for post-synaptic dopamine hypersensitivity in the TIDA-pituitary pathway in patients with tardive dyskinesia, consistent with other reports assessing hormonal responses to dopamine agonists in such cases. It is further suggested that neuroleptic-induced dopamine hypersensitivity does not occur in the TIDA-pituitary system in humans, since it was not manifest in these tardive dyskinesia patients who would be thought particularly prone to develop it.
迟发性运动障碍被推测是由抗精神病药物引起的黑质纹状体系统多巴胺超敏反应所致。本研究使用多巴胺拮抗剂评估了这种多巴胺超敏反应是否扩展至结节漏斗多巴胺(TIDA)系统的可能性,该系统通过抑制作用调节垂体催乳素分泌。在四种情况下评估了6例迟发性运动障碍患者的血浆催乳素浓度:慢性氟哌啶醇治疗期间;氟哌啶醇突然停药后连续评估;未接受药物治疗时;以及对0.5mg肌内注射氟哌啶醇的急性剂量的反应。在所有四种情况下,催乳素反应与正常受试者和无迟发性运动障碍的精神分裂症患者中观察到的反应无差异。得出的结论是,没有证据表明迟发性运动障碍患者的TIDA-垂体途径存在突触后多巴胺超敏反应,这与评估此类病例中激素对多巴胺激动剂反应的其他报告一致。进一步表明,抗精神病药物引起的多巴胺超敏反应在人类TIDA-垂体系统中不会发生,因为在这些被认为特别容易发生这种反应的迟发性运动障碍患者中并未表现出来。